These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 1985744)

  • 1. Obesity and body fat distribution and breast cancer prognosis.
    Schapira DV; Kumar NB; Lyman GH; Cox CE
    Cancer; 1991 Jan; 67(2):523-8. PubMed ID: 1985744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Abdominal obesity and breast cancer risk.
    Schapira DV; Kumar NB; Lyman GH; Cox CE
    Ann Intern Med; 1990 Feb; 112(3):182-6. PubMed ID: 2297194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Factors affecting estrogen and progesterone receptors in primary breast cancer].
    Kuno K; Fukami A; Hori M; Kasumi F; Yoshimoto K
    Gan No Rinsho; 1983 May; 29(6):621-7. PubMed ID: 6876431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Body weight and prognostic indicators in breast cancer. Modifying effect of estrogen receptors.
    Verreault R; Brisson J; Deschênes L; Naud F
    Am J Epidemiol; 1989 Feb; 129(2):260-8. PubMed ID: 2912039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Obesity and subcutaneous fat patterning in relation to survival of postmenopausal breast cancer patients participating in the DOM-project.
    den Tonkelaar I; de Waard F; Seidell JC; Fracheboud J
    Breast Cancer Res Treat; 1995 May; 34(2):129-37. PubMed ID: 7647330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Obesity and subcutaneous fat patterning in relation to breast cancer in postmenopausal women participating in the Diagnostic Investigation of Mammary Cancer Project.
    den Tonkelaar I; Seidell JC; Collette HJ; de Waard F
    Cancer; 1992 Jun; 69(11):2663-7. PubMed ID: 1571895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Body fat distribution and obesity in pre- and postmenopausal breast cancer.
    Sonnenschein E; Toniolo P; Terry MB; Bruning PF; Kato I; Koenig KL; Shore RE
    Int J Epidemiol; 1999 Dec; 28(6):1026-31. PubMed ID: 10661643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Body mass index (BMI) and breast cancer: impact on tumor histopathologic features, cancer subtypes and recurrence rate in pre and postmenopausal women.
    Biglia N; Peano E; Sgandurra P; Moggio G; Pecchio S; Maggiorotto F; Sismondi P
    Gynecol Endocrinol; 2013 Mar; 29(3):263-7. PubMed ID: 23174088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Body size, physical activity, and breast cancer hormone receptor status: results from two case-control studies.
    Enger SM; Ross RK; Paganini-Hill A; Carpenter CL; Bernstein L
    Cancer Epidemiol Biomarkers Prev; 2000 Jul; 9(7):681-7. PubMed ID: 10919738
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T1a and T1b breast cancer: a twelve-year experience.
    Visser TJ; Haan M; Keidan R; Lucas R; Ingold J; Glover J; Riggo P
    Am Surg; 1997 Jul; 63(7):621-6. PubMed ID: 9202537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The associations of obesity, lymph node status and prognosis in breast cancer patients: dependence on estrogen and progesterone receptor status.
    Maehle BO; Tretli S; Thorsen T
    APMIS; 2004 Jun; 112(6):349-57. PubMed ID: 15511272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Variation in body fat distribution and breast cancer risk in the families of patients with breast cancer and control families.
    Schapira DV; Kumar NB; Lyman GH
    Cancer; 1993 May; 71(9):2764-8. PubMed ID: 8467456
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation of tumor size and axillary lymph node involvement with prognosis in patients with T1 breast carcinoma.
    Abner AL; Collins L; Peiro G; Recht A; Come S; Shulman LN; Silver B; Nixon A; Harris JR; Schnitt SJ; Connolly JL
    Cancer; 1998 Dec; 83(12):2502-8. PubMed ID: 9874455
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Body fat distribution and breast cancer in the Framingham Study.
    Ballard-Barbash R; Schatzkin A; Carter CL; Kannel WB; Kreger BE; D'Agostino RB; Splansky GL; Anderson KM; Helsel WE
    J Natl Cancer Inst; 1990 Feb; 82(4):286-90. PubMed ID: 2299677
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Obesity, estrogen production, and tumor estrogen receptors in women with carcinoma of the breast.
    Donegan WL; Johnstone MF; Biedrzycki L
    Am J Clin Oncol; 1983 Feb; 6(1):19-24. PubMed ID: 6837504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estrogen receptors and the pattern of relapse in breast cancer.
    Qazi R; Chuang JL; Drobyski W
    Arch Intern Med; 1984 Dec; 144(12):2365-7. PubMed ID: 6508445
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of obesity on presentation of breast cancer, lymph node metastasis and patient survival: a retrospective review.
    Kaviani A; Neishaboury M; Mohammadzadeh N; Ansari-Damavandi M; Jamei K
    Asian Pac J Cancer Prev; 2013; 14(4):2225-9. PubMed ID: 23725117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell kinetics as a predictive factor in node-positive breast cancer treated with adjuvant hormone therapy.
    Silvestrini R; Daidone MG; Mastore M; Di Fronzo G; Coradini D; Boracchi P; Squicciarini P; Salvadori B; Veronesi U
    J Clin Oncol; 1993 Jun; 11(6):1150-5. PubMed ID: 8501501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Obesity at diagnosis of breast carcinoma influences duration of disease-free survival.
    Senie RT; Rosen PP; Rhodes P; Lesser ML; Kinne DW
    Ann Intern Med; 1992 Jan; 116(1):26-32. PubMed ID: 1727092
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lymphatic invasion, tumor size, and age are independent predictors of axillary lymph node metastases in women with T1 breast cancers.
    Gajdos C; Tartter PI; Bleiweiss IJ
    Ann Surg; 1999 Nov; 230(5):692-6. PubMed ID: 10561094
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.